Mark Schneyer
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Mark C.
Schneyer is Chief Financial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, Mr. Schneyer was Vice President-Business Development at Pfizer Inc. from 2019 to 2020.
Mr. Schneyer completed undergraduate studies at The Wharton School of the University of Pennsylvania in 1996.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 66 145 ( 0,04% ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Directeur Financier/CFO | 10/09/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/05/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national